The FDA approved Yutrepia inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

Adolescents with mental health issues who were admitted to a pediatric inpatient psychiatry unit experienced significant ...

Children and young adults in states with high Medicaid disenrollment rates were more likely to experience disruptions in ...

Bausch + Lomb launched a preservative-free form of Lumify redness-reducing eye drops in the U.S., according to a press ...

In ALS, a neurodegenerative condition that leads to loss of muscle control and executive function, there is a need for ...

A hand hygiene intervention, which encouraged patients and visitors to the participating units to perform audits of health ...

A few years ago at the ASCRS meeting, I had the chance to present in a session called “The Best of ASCRS” in which we ...

A combination of unsupervised and supervised machine learning algorithms may be able to assist clinicians in identifying ...

The FDA granted approval to mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Long-term outcomes after CT or invasive coronary angiography to diagnose CAD were similar, with comparable improvement in ...

Alterations in the size and number of moles are commonly reported among the many changes taking place during pregnancy; ...